Exopolysaccharide-producing probiotic lactobacilli reduce serum cholesterol and modify enteric microbiota in apoE-deficient mice

Journal of Nutrition

Volumn 144, Issue 12, 2014, Pages 1956-1962

  London, Lis E E ^a,c   Kumar, Arun H S ^b   Wall, Rebecca ^a   Casey, Pat G ^a,b   O'Sullivan, Orla ^c   Shanahan, Fergus ^a   Hill, Colin ^a,b   Cotter, Paul D ^a,c   Fitzgerald, Gerald F ^a,b   Ross, Paul ^a,b   Caplice, Noel M ^b   Stanton, Catherine ^a,c  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c TEAGASC FOOD RESEARCH CENTRE   (Ireland)

Author keywords

Cholesterol; Exopolysaccharide; Gut microbiota; Lactobacilli; Lipid metabolism; Probiotics

Indexed keywords

APOLIPOPROTEIN E; EXOPOLYSACCHARIDE; GLYCOSYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PROBIOTIC AGENT; TRIACYLGLYCEROL; BETA GLUCAN; CHOLESTEROL; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ATHEROSCLEROSIS; ARTICLE; BACTERIAL GENE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; INTESTINE FLORA; LACTOBACILLUS PARACASEI; LIPID LIVER LEVEL; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; ATHEROSCLEROSIS; BLOOD; DIET; DISEASE MODEL; ENZYMOLOGY; FECES; GASTROINTESTINAL TRACT; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; LACTOBACILLUS; LIVER; METABOLISM; MICROBIOLOGY; MICROFLORA; PEDIOCOCCUS;

MUS;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BETA-GLUCANS; CHOLESTEROL; DIET; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FECES; GASTROINTESTINAL TRACT; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLYCOSYLTRANSFERASES; LACTOBACILLUS; LIPID METABOLISM; LIVER; MICE; MICE, KNOCKOUT; MICROBIOTA; PEDIOCOCCUS; PROBIOTICS; TRIGLYCERIDES; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84912036309     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.114.191627     Document Type: Article

References (45)

1. FAO/WHO. Interim summary of conclusions and dietary recommendations on total fat & fatty acids. From the Joint FAO/WHO Expert Consultation on Fats and Fatty Acids in Human Nutrition, 10-14 November 2008, WHO, Geneva. Available from: http://www.who.int/ nutrition/topics/FFA_summary_rec_conclusion.pdf?ua=1.
2. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology-human gut microbes associated with obesity. Nature 2006;444:1022-3.
3. Dumas ME, Barton RH, Toye A, Cloarec O, Blancher C, Rothwell A, Fearnside J, Tatoud R, Blanc V, Lindon JC, et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci USA 2006;103:12511-6.
4. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, Feldstein AE, Britt EB, Fu XM, Chung YM, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011; 472:57-63.
5. Lam V, Su JD, Koprowski S, Hsu A, Tweddell JS, Rafiee P, Gross GJ, Salzman NH, Baker JE. Intestinal microbiota determine severity of myocardial infarction in rats response. FASEB J 2012;26:4388-9.
6. Karlsson FH, Fak F, Nookaew I, Tremaroli V, Fagerberg B, Petranovic D, Backhed F, Nielsen J. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun 2012;3:1245.
7. Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, Britt EB, Fu X, Wu Y, Li L, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 2013;19:576-85.
8. Marlett JA, McBurney MI, Slavin JL. Position of the American Dietetic Association: health implications of dietary fiber. J Am Diet Assoc 2002; 102:993-1000.
9. FDA. A rule by the Food and Drug Administration. Food labeling: health claims: oat and coronary heart disease. Federal Register. 2010;62:15.
10. Wilson TA, Nicolosi RJ, Delaney B, Chadwell K, Moolchandani V, Kotyla T, Ponduru S, Zheng GH, Hess R, Knutson N, et al. Reduced and high molecular weight barley beta-glucans decrease plasma total and non-HDL-cholesterol in hypercholesterolemic Syrian golden hamsters. J Nutr 2004;134:2617-22.
11. Nicolosi R, Bell SJ, Bistrian BR, Greenberg I, Forse RA, Blackburn GL. Plasma lipid changes after supplementation with beta-glucan fiber from yeast. Am J Clin Nutr 1999;70:208-12.
12. Ganzle M, Michael G, Schwab C. Exopolysaccharide production by intestinal lactobacilli. In: Tannock GW, editor. Probiotics & Prebiotics: Scientific Aspects. Norfolk: Caister Academic Press. 2005.
13. Garai-Ibabe G, Dueñas MT, Irastorza A, Sierra-Filardi E, Werning ML, López P, Corbí AL, Fernández de Palencia P. Naturally occurring 2-substituted (1,3)-beta-D-glucan producing Lactobacillus suebicus and Pediococcus parvulus strains with potential utility in the production of functional foods. Bioresour Technol 2010;101:9254-63.
14. Kim Y, Oh S, Kim SH. Released exopolysaccharide (r-EPS) produced from probiotic bacteria reduce biofilm formation of enterohemorrhagic Escherichia coli O157:H7. Biochem Biophys Res Commun 2009; 379:324-9.
15. Rodríguez C, Medici M, Rodriguez AV, Mozzi F, de Valdez GF. Prevention of chronic gastritis by fermented milks made with exopolysaccharideproducing Streptococcus thermophilus strains. J Dairy Sci 2009;92: 2423-34.
16. Hong K, Jang KH, Lee JC, Kim S, Kim MK, Lee IY, Kim SM, Lim YH, Kang SA. Bacterial beta-glucan exhibits potent hypoglycemic activity via decrease of serum lipids and adiposity, and increase of UCP mRNA expression. J Microbiol Biotechnol 2005;15:823-30.
17. Nakajima H, Suzuki Y, Kaizu H, Hirota T. Cholesterol lowering activity of ropy fermented milk. J Food Sci 1992;57:1327-9.
18. Maeda H, Zhu X, Suzuki S, Suzuki K, Kitamura S. Structural characterization and biological activities of an exopolysaccharide kefiran produced by Lactobacillus kefiranofaciens WT-2B(T). J Agric Food Chem 2004;52:5533-8.
19. Uchida M, Ishii I, Inoue C, Akisato Y, Watanabe K, Hosoyama S, Toida T, Ariyoshi N, KitadaM. Kefiran reduces atherosclerosis in rabbits fed a high cholesterol diet. J Atheroscler Thromb 2010;17:980-8.
20. Martensson O, Biorklund M, Lambo AM, Duenas-Chasco M, Irastorza A, Holst O, Norin E, Welling G, Oste R, Onning G. Fermented, ropy, oat-based products reduce cholesterol levels and stimulate the bifidobacteria flora in humans. Nutr Res 2005;25:429-42.
21. Stack HM, Kearney N, Stanton C, Fitzgerald GF, Ross RP. Association of beta-glucan endogenous production with increased stress tolerance of intestinal lactobacilli. Appl Environ Microbiol 2010;76:500-7.
22. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. Apoedeficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 1994;14:133-40.
23. Dhar MS, Sommardahl CS, Kirkland T, Nelson S, Donnell R, Johnson DK, Castellani LW. Mice heterozygous for Atp10c, a putative amphipath, represent a novel model of obesity and type 2 diabetes. J Nutr 2004; 134:799-805.
24. Wall R, Ross RP, Shanahan F, O'Mahony L, O'Mahony C, Coakley M, Hart O, Lawlor P, Quigley EM, Kiely B, et al. Metabolic activity of the enteric microbiota influences the fatty acid composition of murine and porcine liver and adipose tissues. Am J Clin Nutr 2009;89:1393-401.
25. Koga M, Kai H, Yasukawa H, Yamamoto T, Kawai Y, Kato S, Kusaba K, Kai M, Egashira K, Kataoka Y, et al. Inhibition of progression and stabilization of plaques by postnatal interferon-gamma function blocking in apoE-knockout mice. Circ Res 2007;101:348-56.
26. Koga M, Kai H, Yasukawa H, Kato S, Yamamoto T, Kawai Y, Kusaba K, Seki Y, Kai M, Egashira K, et al. Postnatal blocking of interferon-gamma function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice. Hypertens Res 2007;30:259-67.
27. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957; 226:497-509.
28. Van der Meer R, De Vries HT, Glatz JFC. t-Butanol extraction of feces: a rapid procedure for enzymatic determination of fecal bile acids. Beynen AC, Geelen MJH, Katan MB, Schouten JA, eds. Cholesterol metabolism in health and disease. Wageningen: Ponsen and Looyen; 1985:113-9.
29. Han SH, Chung MJ, Lee SJ, Rhee C. Digestion-resistant fraction from soybean [Glycine max (L.) Merrill] induces hepatic LDL receptor and CYP7A1 expression in apolipoprotein E-deficient mice. J Nutr Biochem 2006;17:682-8.
30. Fouhy F, Guinane CM, Hussey S, Wall R, Ryan CA, Dempsey EM, Murphy B, Ross RP, Fitzgerald GF, Stanton C, et al. High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin. Antimicrob Agents Chemother 2012;56:5811-20.
31. Claesson MJ, O'Sullivan O, Wang Q, Nikkila J, Marchesi JR, Smidt H, de Vos WM, Ross RP, O'Toole PW. Comparative analysis of pyrosequencing and a phylogeneticmicroarray for exploringmicrobial community structures in the human distal intestine. PLoS ONE 2009;4:e6669.
32. Huson DH, Auch AF, Qi J, Schuster SC. MEGAN analysis of metagenomic data. Genome Res 2007;17:377-86.
33. Urich T, Lanzen A, Qi J, Huson DH, Schleper C, Schuster SC. Simultaneous assessment of soil microbial community structure and function through analysis of the meta-transcriptome. PLoS ONE 2008;3:e2527.
34. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Pena AG, Goodrich JK, Gordon JI, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 2010;7:335-6.
35. Haas BJ, Gevers D, Earl AM, Feldgarden M, Ward DV, Giannoukos G, Ciulla D, Tabbaa D, Highlander SK, Sodergren E, et al. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res 2011;21:494-504.
36. Price MN, Dehal PS, Arkin AP. FastTree 2-approximately maximumlikelihood trees for large alignments. PLoS ONE 2010;5:e9490.
37. Wall R, Marques TM, O'Sullivan O, Ross RP, Shanahan F, Quigley E, Dinan TG, Kiely B, Fitzgerald GF, Cotter PD, et al. Contrasting effects of Bifidobacterium breve NCIMB 702258 and Bifidobacterium breve DPC 6330 on the composition of murine brain fatty acids and gut microbiota. Am J Clin Nutr 2012;95:1278-87.
38. Wang J, Zhang H, Chen X, Chen Y, Menghebilige, Bao Q. Selection of potential probiotic lactobacilli for cholesterol-lowering properties and their effect on cholesterol metabolism in rats fed a high-lipid diet. J Dairy Sci 2012;95:1645-54.
39. Dueland S, Drisko J, Graf L, Machleder D, Lusis AJ, Davis RA. effect of dietary-cholesterol and taurocholate on cholesterol 7-alphahydroxylase and hepatic Ldl receptors in inbred mice. J Lipid Res 1993;34:923-31.
40. Meir KS, Leitersdorf E. Atherosclerosis in the apolipoprotein E-deficient mouse-a decade of progress. Arterioscler Thromb Vasc Biol 2004;24: 1006-14.
41. Chen L, Liu WE, Li YM, Luo S, Liu QX, Zhong YM, Jian ZJ, Bao MH. Lactobacillus acidophilus ATCC 4356 attenuates the atherosclerotic progression through modulation of oxidative stress and inflammatory process. Int Immunopharmacol 2013;17:108-15.
42. Cockerill GW, Rye KA, Gamble JR, Vadas MA, Barter PJ. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol 1995;15:1987-94.
43. De Backer J, Mak R, De Bacquer D, Van Renterghem L, Verbraekel E, Kornitzer M, De Backer G. Parameters of inflammation and infection in a community based case-control study of coronary heart disease. Atherosclerosis 2002;160:457-63.
44. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP, et al. A core gut microbiome in obese and lean twins. Nature 2009;457:480-4.
45. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006;444:1027-31.